Home › Irritable Bowel Syndrome › Minnesota
Irritable Bowel Syndrome clinical trials in Minnesota
3 studies for Irritable Bowel Syndrome are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
- Mayo Clinic in Rochester, Minnesota, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07545759Mucosal and Microbiota Changes During Acute Campylobacteriosis
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Aug 7, 2026 · NCT03223077Fecal Microbiota Transplantation for IBS
- Mayo Clinic in Minnesota, Rochester
RecruitingPhase 2
Ages 18 to 70 · Women · Updated May 8, 2026 · NCT05776914From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.